Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 1
1976 1
1978 1
1980 1
1999 1
2001 1
2002 1
2003 2
2004 3
2005 2
2006 6
2007 6
2008 8
2009 8
2010 6
2011 5
2012 3
2013 3
2014 2
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 16880450

59 results
Results by year
Filters applied: . Clear all
Page 1
Rosiglitazone and macular edema.
Sivagnanam G. Sivagnanam G. CMAJ. 2006 Aug 1;175(3):276. doi: 10.1503/cmaj.1060089. CMAJ. 2006. PMID: 16880450 Free PMC article. No abstract available.
Rosiglitazone (Avandia) and macular edema.
Kendall C, Wooltorton E. Kendall C, et al. CMAJ. 2006 Feb 28;174(5):623. doi: 10.1503/cmaj.060074. Epub 2006 Feb 8. CMAJ. 2006. PMID: 16467508 Free PMC article. No abstract available.
[The decline of rosiglitazone].
Johansen K. Johansen K. Ugeskr Laeger. 2008 Mar 17;170(12):1063. Ugeskr Laeger. 2008. PMID: 18401914 Danish. No abstract available.
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association. Nesto RW, et al. Circulation. 2003 Dec 9;108(23):2941-8. doi: 10.1161/01.CIR.0000103683.99399.7E. Circulation. 2003. PMID: 14662691 Review. No abstract available.
[Rosiglitazone].
Johansen K. Johansen K. Ugeskr Laeger. 2010 Sep 20;172(38):2631; author reply 2631. Ugeskr Laeger. 2010. PMID: 20931733 Danish. No abstract available.
Thiazolidinediones and the risk of edema: a meta-analysis.
Berlie HD, Kalus JS, Jaber LA. Berlie HD, et al. Diabetes Res Clin Pract. 2007 May;76(2):279-89. doi: 10.1016/j.diabres.2006.09.010. Epub 2006 Oct 18. Diabetes Res Clin Pract. 2007. PMID: 17055103
[Therapy with glitazones--a risk for cardiovascular disease?].
Rottlaender D, Michels G, Erdmann E, Hoppe UC. Rottlaender D, et al. Dtsch Med Wochenschr. 2007 Dec;132(49):2629-32. doi: 10.1055/s-2007-993110. Dtsch Med Wochenschr. 2007. PMID: 18050028 Review. German.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S; DREAM investigators. Bailey SD, et al. Diabetes Care. 2010 Oct;33(10):2250-3. doi: 10.2337/dc10-0452. Epub 2010 Jul 13. Diabetes Care. 2010. PMID: 20628086 Free PMC article.
59 results
Jump to page
Feedback